Free Trial
OTC:BBLG

Bone Biologics (BBLG) Stock Price, News & Analysis

Bone Biologics logo
$3.49 -0.13 (-3.59%)
As of 07/3/2025 01:00 PM Eastern

About Bone Biologics Stock (OTC:BBLG)

Key Stats

Today's Range
$3.49
$3.65
50-Day Range
$3.49
$6.20
52-Week Range
$3.35
$25.50
Volume
131,126 shs
Average Volume
260,817 shs
Market Capitalization
$1.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BBLG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bone Biologics and its competitors with MarketBeat's FREE daily newsletter.

BBLG Stock News Headlines

BBLG Moves Toward Commercialization
BBLG Splits to Advance
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
Bone Biologics Announces Pricing Of $2 Mln Public Offering
See More Headlines

BBLG Stock Analysis - Frequently Asked Questions

Bone Biologics' stock was trading at $5.6418 on January 1st, 2025. Since then, BBLG shares have decreased by 38.1% and is now trading at $3.49.

Bone Biologics Co. (OTC:BBLG) posted its quarterly earnings data on Monday, August, 14th. The company reported ($10.14) earnings per share for the quarter, missing the consensus estimate of ($9.00) by $1.14.

Bone Biologics's stock reverse split on Tuesday, June 10th 2025.The 1-6 reverse split was announced on Monday, June 9th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Monday, June 9th 2025. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split.

Shares of BBLG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bone Biologics investors own include Pfizer (PFE), NVIDIA (NVDA), Meta Platforms (META), PayPal (PYPL), Advanced Micro Devices (AMD), Canopy Growth (CGC) and Cisco Systems (CSCO).

Company Calendar

Last Earnings
8/14/2023
Today
7/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTC
Sector
Medical
Industry
Medical Devices
Sub-Industry
Medical Equipment
Current Symbol
OTC:BBLG
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$1.49 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$1.82 per share
Price / Book
1.92

Miscellaneous

Free Float
2,886,000
Market Cap
$1.90 million
Optionable
Not Optionable
Beta
0.69
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (OTC:BBLG) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners